JP2024534847A5 - - Google Patents
Info
- Publication number
- JP2024534847A5 JP2024534847A5 JP2024513196A JP2024513196A JP2024534847A5 JP 2024534847 A5 JP2024534847 A5 JP 2024534847A5 JP 2024513196 A JP2024513196 A JP 2024513196A JP 2024513196 A JP2024513196 A JP 2024513196A JP 2024534847 A5 JP2024534847 A5 JP 2024534847A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- hcdr2
- hcdr1
- hcdr3
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111004998 | 2021-08-30 | ||
| CN202111004998.9 | 2021-08-30 | ||
| PCT/CN2022/115590 WO2023030272A1 (zh) | 2021-08-30 | 2022-08-29 | 抗gprc5d抗原结合蛋白及其用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024534847A JP2024534847A (ja) | 2024-09-26 |
| JP2024534847A5 true JP2024534847A5 (enExample) | 2025-03-14 |
| JP7889885B2 JP7889885B2 (ja) | 2026-07-14 |
Family
ID=85410857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513196A Active JP7889885B2 (ja) | 2021-08-30 | 2022-08-29 | 抗ｇｐｒｃ５ｄ抗原結合タンパク質とその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240384001A1 (enExample) |
| EP (1) | EP4397686A4 (enExample) |
| JP (1) | JP7889885B2 (enExample) |
| CN (1) | CN116063500A (enExample) |
| WO (1) | WO2023030272A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118541399A (zh) * | 2022-01-14 | 2024-08-23 | 原启生物科技(上海)有限责任公司 | 靶向gprc5d的嵌合抗原受体及其用途 |
| CN120882747A (zh) * | 2023-03-22 | 2025-10-31 | 百放英库医药科技(北京)有限公司 | 一种抗gprc5d纳米抗体及其应用 |
| JP2026523614A (ja) * | 2023-07-07 | 2026-07-14 | オーバーランド セラピューティクス （ユーエス） インコーポレイテッド | Ｇｐｒｃ５ｄに対する単一ドメイン抗体 |
| AR133427A1 (es) | 2023-07-31 | 2025-09-24 | Sanofi Sa | Anticuerpos anti-gprc5d y composiciones |
| CN120005019A (zh) * | 2023-11-14 | 2025-05-16 | 成都优赛诺生物科技有限公司 | 一种靶向gprc5d的单域抗体、嵌合抗原受体及其应用 |
| WO2026026960A1 (zh) * | 2024-08-01 | 2026-02-05 | 原启生物科技(上海)有限责任公司 | 一种靶向bcma的人源化纳米抗体及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015357535B2 (en) * | 2014-12-05 | 2020-05-14 | Eureka Therapeutics, Inc. | Antibodies targeting G-protein coupled receptor and methods of use |
| DK3227339T3 (da) | 2014-12-05 | 2022-01-10 | Memorial Sloan Kettering Cancer Center | Kimæriske antigenreceptorer rettet mod g-protein-koblet receptor og anvendelser deraf |
| TWI781108B (zh) * | 2016-07-20 | 2022-10-21 | 比利時商健生藥品公司 | 抗ｇｐｒｃ５ｄ抗體、結合ｇｐｒｃ５ｄ與ｃｄ３之雙特異性抗原結合分子及其用途 |
| TW201837174A (zh) * | 2017-02-07 | 2018-10-16 | 日商第一三共股份有限公司 | 抗ｇｐｒｃ５ｄ抗體及包含該抗體之分子 |
| TWI829667B (zh) * | 2018-02-09 | 2024-01-21 | 瑞士商赫孚孟拉羅股份公司 | 結合gprc5d之抗體 |
| EP3778876A4 (en) * | 2018-03-26 | 2022-01-12 | Origincell Therapeutics Co., Ltd. | METHOD OF PROMOTING IMMUNE CELL PROLIFERATION |
| CN119569895A (zh) * | 2018-11-01 | 2025-03-07 | 朱诺治疗学股份有限公司 | G蛋白偶合受体c类5族成员d(gprc5d)特异性嵌合抗原受体 |
| WO2021018925A1 (en) * | 2019-07-31 | 2021-02-04 | F. Hoffmann-La Roche Ag | Antibodies binding to gprc5d |
| WO2021113780A1 (en) * | 2019-12-06 | 2021-06-10 | Juno Therapeutics, Inc. | Anti-idiotypic antibodies to gprc5d-targeted binding domains and related compositions and methods |
-
2022
- 2022-08-29 CN CN202211041811.7A patent/CN116063500A/zh active Pending
- 2022-08-29 US US18/687,695 patent/US20240384001A1/en active Pending
- 2022-08-29 EP EP22863407.7A patent/EP4397686A4/en active Pending
- 2022-08-29 JP JP2024513196A patent/JP7889885B2/ja active Active
- 2022-08-29 WO PCT/CN2022/115590 patent/WO2023030272A1/zh not_active Ceased